100 related articles for article (PubMed ID: 27487730)
1. Intracellular Elemental Patterns of Apoptosis Resistance in Transdifferentiated Androgen-Dependent Prostatic Carcinoma Cells.
Salido M; Vilches J
Microsc Microanal; 2016 Aug; 22(4):865-77. PubMed ID: 27487730
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptides, apoptosis and ion changes in prostate cancer. Methods of study and recent developments.
Vilches J; Salido M; Fernández-Segura E; Roomans GM
Histol Histopathol; 2004 Jul; 19(3):951-61. PubMed ID: 15168357
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptides bombesin and calcitonin inhibit apoptosis-related elemental changes in prostate carcinoma cell lines.
Salido M; Vilches J; López A; Roomans GM
Cancer; 2002 Jan; 94(2):368-77. PubMed ID: 11900223
[TBL] [Abstract][Full Text] [Related]
4. Isoform 1 of TPD52 (PC-1) promotes neuroendocrine transdifferentiation in prostate cancer cells.
Moritz T; Venz S; Junker H; Kreuz S; Walther R; Zimmermann U
Tumour Biol; 2016 Aug; 37(8):10435-46. PubMed ID: 26846108
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptides bombesin and calcitonin induce resistance to etoposide induced apoptosis in prostate cancer cell lines.
Salido M; Vilches J; López A
Histol Histopathol; 2000 Jul; 15(3):729-38. PubMed ID: 10963117
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine differentiation in prostate carcinoma: focusing on its pathophysiologic mechanisms and pathological features.
Alberti C
G Chir; 2010; 31(11-12):568-74. PubMed ID: 21232206
[TBL] [Abstract][Full Text] [Related]
7. [The influence of neuroendocrine differentiation on the growth and androgen receptor expression of prostate carcinoma cells].
Song Y; Wu G; Xin DQ; Na YQ
Zhonghua Wai Ke Za Zhi; 2004 Dec; 42(23):1453-6. PubMed ID: 15733464
[TBL] [Abstract][Full Text] [Related]
8. hASH1 nuclear localization persists in neuroendocrine transdifferentiated prostate cancer cells, even upon reintroduction of androgen.
Fraser JA; Sutton JE; Tazayoni S; Bruce I; Poole AV
Sci Rep; 2019 Dec; 9(1):19076. PubMed ID: 31836808
[TBL] [Abstract][Full Text] [Related]
9. Changes in elemental concentrations in LNCaP cells are associated with a protective effect of neuropeptides on etoposide-induced apoptosis.
Salido M; Vilches J; Roomans GM
Cell Biol Int; 2004; 28(5):397-402. PubMed ID: 15193283
[TBL] [Abstract][Full Text] [Related]
10. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression.
Cox ME; Deeble PD; Lakhani S; Parsons SJ
Cancer Res; 1999 Aug; 59(15):3821-30. PubMed ID: 10447001
[TBL] [Abstract][Full Text] [Related]
11. Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells.
Berenguer C; Boudouresque F; Dussert C; Daniel L; Muracciole X; Grino M; Rossi D; Mabrouk K; Figarella-Branger D; Martin PM; Ouafik L
Oncogene; 2008 Jan; 27(4):506-18. PubMed ID: 17637748
[TBL] [Abstract][Full Text] [Related]
12. Androgen deprivation of the PC-310 [correction of prohormone convertase-310] human prostate cancer model system induces neuroendocrine differentiation.
Jongsma J; Oomen MH; Noordzij MA; Van Weerden WM; Martens GJ; van der Kwast TH; Schröder FH; van Steenbrugge GJ
Cancer Res; 2000 Feb; 60(3):741-8. PubMed ID: 10676662
[TBL] [Abstract][Full Text] [Related]
13. NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.
Jin RJ; Wang Y; Masumori N; Ishii K; Tsukamoto T; Shappell SB; Hayward SW; Kasper S; Matusik RJ
Cancer Res; 2004 Aug; 64(15):5489-95. PubMed ID: 15289359
[TBL] [Abstract][Full Text] [Related]
14. Etoposide sensitivity of human prostatic cancer cell lines PC-3, DU 145 and LNCaP.
Salido M; Larrán J; López A; Vilches J; Aparicio J
Histol Histopathol; 1999 Jan; 14(1):125-34. PubMed ID: 9987657
[TBL] [Abstract][Full Text] [Related]
15. MnSOD drives neuroendocrine differentiation, androgen independence, and cell survival in prostate cancer cells.
Quiros-Gonzalez I; Sainz RM; Hevia D; Mayo JC
Free Radic Biol Med; 2011 Feb; 50(4):525-36. PubMed ID: 21056653
[TBL] [Abstract][Full Text] [Related]
16. Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.
Yuan TC; Veeramani S; Lin FF; Kondrikou D; Zelivianski S; Igawa T; Karan D; Batra SK; Lin MF
Endocr Relat Cancer; 2006 Mar; 13(1):151-67. PubMed ID: 16601285
[TBL] [Abstract][Full Text] [Related]
17. Release of macrophage migration inhibitory factor by neuroendocrine-differentiated LNCaP cells sustains the proliferation and survival of prostate cancer cells.
Tawadros T; Alonso F; Jichlinski P; Clarke N; Calandra T; Haefliger JA; Roger T
Endocr Relat Cancer; 2013 Feb; 20(1):137-49. PubMed ID: 23207293
[TBL] [Abstract][Full Text] [Related]
18. [Effect of the neuropeptides bombesin and calcitonin on the growth of prostate cell lines, PC-3, DU 145, and LNCaP].
Larrán López J; Aparicio Patino J; López Muñoz A; Vilches Troya J
Actas Urol Esp; 2000; 24(10):779-84. PubMed ID: 11199293
[TBL] [Abstract][Full Text] [Related]
19. Regulation of neuroendocrine differentiation by AKT/hnRNPK/AR/β-catenin signaling in prostate cancer cells.
Ciarlo M; Benelli R; Barbieri O; Minghelli S; Barboro P; Balbi C; Ferrari N
Int J Cancer; 2012 Aug; 131(3):582-90. PubMed ID: 22015967
[TBL] [Abstract][Full Text] [Related]
20. Development of an androgen-deprivation induced and androgen suppressed human prostate cancer cell line.
Lee SO; Dutt SS; Nadiminty N; Pinder E; Liao H; Gao AC
Prostate; 2007 Sep; 67(12):1293-300. PubMed ID: 17626246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
